Rheumatology Patient Registry and Biorepository
NCT04402086 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000
Last updated 2026-02-13
Summary
To facilitate clinical, basic science, and translational research projects involving the study of rheumatic diseases.
Conditions
- Rheumatic Diseases
- Adult Onset Still Disease
- Ankylosing Spondylitis
- Psoriatic Arthritis
- Reactive Arthritis
- Antiphospholipid Syndrome
- Systemic Lupus Erythematosus
- Behcet Disease
- Dermatomyositis
- Polymyositis
- Giant Cell Arteritis
- Lyme Disease
- Mixed Connective Tissue Disease
- Polymyalgia Rheumatica
- Rheumatoid Arthritis
- Sarcoidosis
- Systemic Sclerosis
- Scleroderma
- Sjogren's Syndrome
- Undifferentiated Connective Tissue Diseases
Sponsors & Collaborators
-
Rheumatology Research Foundation
collaborator OTHER -
Yale University
lead OTHER
Principal Investigators
-
Monique Hinchcliff, MD · Yale University
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-08-04
- Primary Completion
- 2030-06-01
- Completion
- 2030-06-01
Countries
- United States
Study Locations
More Related Trials
-
Subgrouping SLE - a New Approach to Understand the Pathogenesis and Improve Treatment
NCT07102030 ·Status: RECRUITING
-
Next Generation Pathogen Sequencing for Prediction of Infection in Rheumatic Disease
NCT04226261 ·Status: UNKNOWN
-
Study of Systemic Lupus Erythematosus
NCT00001372 ·Status: RECRUITING
-
Medical Follow-up of New Cases of Polyarthritis in Children and Young Adults
NCT07000916 ·Status: RECRUITING
-
Determining the Responses and Impact of Rituximab-instigated Cell Depletion on T Cells in People With SLE
NCT01702038 ·Status: WITHDRAWN ·Phase: PHASE2
-
Molecular Diagnosis of Systemic Autoinflammatory Diseases
NCT05364294 ·Status: RECRUITING
-
Gut Microbiota Dysbiosis in Lupus Nephritis
NCT06231303 ·Status: NOT_YET_RECRUITING
-
Rituximab Objective Outcome Measures Trial in SLE
NCT03054259 ·Status: UNKNOWN ·Phase: PHASE2
-
Duke Lupus Registry
NCT00512694 ·Status: RECRUITING
-
Biomarkers in Inflammatory Rheumatic Diseases Diagnosis
NCT06778343 ·Status: RECRUITING
-
A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
NCT02034344 ·Status: COMPLETED
-
Biocollection of Rare Pediatric-onset of Autoimmune and Autoinflammatory Diseases
NCT06435468 ·Status: RECRUITING ·Phase: NA
-
Study of the Role of Soluble Forms of RAGE (sRAGE/esRAGE) as Diagnostic and Prognostic Biomarkers of Systemic Lupus Erythematosus.
NCT02891213 ·Status: UNKNOWN
-
Disease Activity Biomarkers in Patients With Systemic Lupus Erythematosus
NCT05443516 ·Status: RECRUITING
-
Duke Autoimmunity in Pregnancy Registry
NCT00513591 ·Status: COMPLETED
-
Study of Leukocyte Populations in Patients With Chronic Inflammatory
NCT04749875 ·Status: NOT_YET_RECRUITING
-
Open Label Pilot Trial of Rituximab in Lupus Membranous Nephritis
NCT00908986 ·Status: WITHDRAWN ·Phase: NA
-
Pilot Study of Rituximab Therapy for Systemic Lupus Erythematosus (SLE) and Vasculitis
NCT00293072 ·Status: COMPLETED ·Phase: PHASE2
-
Biomarkers in Autoimmune Diseases, Vasculitis and Auto Inflammatory Diseases
NCT05383339 ·Status: RECRUITING
-
Precision Medicine in LN: A Multicenter Proof-of-concept Study for Histopathological Biomarkers Analysis in Renal Biopsy
NCT05358652 ·Status: UNKNOWN
-
Study of RC18 Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus(SLE)
NCT02885610 ·Status: COMPLETED ·Phase: PHASE2
-
Application of MRI for Musculoskeletal Involvement in SLE
NCT04035265 ·Status: UNKNOWN ·Phase: NA
-
RLIP76 in Human Serum in Adults With Rheumatologic Diseases
NCT00861159 ·Status: WITHDRAWN
-
A Study to Learn More About the Safety and Effects of Felzartamab in Adults With Lupus Nephritis Aged 18 to 75 Years Old
NCT06064929 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Cardiac and Laboratory Findings in Patients With Systemic Lupus Erythematosus
NCT03179046 ·Status: COMPLETED